Product Information
FT MOTION SICKNESS 25 MG TAB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1281 per EA under NDC 70677108801. Its NADAC has been published 156 times since Oct 11, 2023.
Strength
25 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677108801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M009On Market Since
4/6/2023
Pharmacological Classes
Price Statistics
The NADAC for FT MOTION SICKNESS 25 MG TAB has been published 156 times since Oct 11, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1281 per EA |
|---|---|
| All-time high | $0.1651 (Nov 15, 2023) |
| All-time low | $0.0824 (Jan 17, 2024) |
| 52-week high | $0.1344 |
| 52-week low | $0.1252 |
| Median price | $0.1288 |
| Average price | $0.1282 |
| Largest weekly change | +62.0% (Mar 20, 2024) |
| Weeks tracked | 156 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Meclizine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiemetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT MOTION SICKNESS 25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FT MOTION SICKNESS 25 MG TAB, manufactured by Strategic Sourcing Services LLC, is $0.1281 per EA (NDC 70677108801), effective Sep 30, 2026.
How has the price of FT MOTION SICKNESS 25 MG TAB changed over time?
Over the history we have for it, the NADAC for FT MOTION SICKNESS 25 MG TAB has held within roughly two percent of its current level. It has been tracked across 156 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for FT MOTION SICKNESS 25 MG TAB?
Since Oct 11, 2023, the NADAC for FT MOTION SICKNESS 25 MG TAB has ranged from a low of $0.0824 (Jan 17, 2024) to a high of $0.1651 (Nov 15, 2023), with a median of $0.1288 per EA.
Are there cheaper alternatives to FT MOTION SICKNESS 25 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GNP MOTION SICKNESS 25 MG CHWTB, is $0.0333 per EA — about 74% below FT MOTION SICKNESS 25 MG TAB.
Who manufactures FT MOTION SICKNESS 25 MG TAB?
FT MOTION SICKNESS 25 MG TAB (NDC 70677108801) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.